Specialty Pharmacy

Top news of the day from across the health care landscape.

The Guide to Hepatitis C Testing addresses widespread uncertainty regarding HCV treatment.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Keytruda demonstrated statistically significant improvements in overall survival.

The criminalization of drug use could be detrimental to HIV patient health and does not decrease use, study suggests.

Southern Italy tomato varieties demonstrated a potential role against typical neoplastic features.

Top news of the day from across the health care landscape.

Jonathan Van Lare, PharmD, director of Pharmacy Advantage, discusses the growth of biosimilars in specialty pharmacy.

The approval triples the number of rare gene mutations that ivacaftor can now treat.

CMS seeks to aid states in creation of high-risk pools and state-operated reinsurance programs.

Pharma manufacturers in the future will reimburse payers on payments for ineffective therapies based on outcomes.

Consumption of soy may mitigate markers of colonic inflammation.

Top news of the day from across the health care landscape.

FDA issues safety warning for canagliflozin in the treatment of type 2 diabetes.

Nanoparticle precisely delivers tumor antigens to immune cells while stimulating immunity.

Breast cancer incidence has climbed among Asian Americans, while diagnosis rates among other groups have trended downward.

An improved test for Zika virus could prevent birth defects.

Investing in diagnostic resources, prevention, and treatment programs are vital to ending the HIV epidemic in the United States.

Tracking unstable chromosomes allows scientists to peer into the evolution of NSCLC.

Top news of the day from across the health care landscape.

Cheryl Allen, vice president of Industry Relations at Diplomat, discusses how specialty pharmacies can differentiate themselves from the competition.

Adherence to diabetes therapy related to the high cost of treatment.

Keytruda found to improve the overall response rate in pediatric and adult patients with cHL.

Study found no statistically significant differences when switching from biologic to biosimilar.

Study examines how bacteria in the digestive tract might increase or decrease response to cancer drugs.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses how specialty pharmacists can help patients manage adverse events from their treatment regimen.

The World Health Organization recently announced plans to launch a pilot program for prequalifying biosimilars.

Top news of the day from across the health care landscape.